tiprankstipranks
Trending News
More News >
Vicore Pharma Holding AB (DE:6Y4)
FRANKFURT:6Y4
Germany Market

Vicore Pharma Holding AB (6Y4) Income Statement

Compare
2 Followers

Vicore Pharma Holding AB Income Statement

Last quarter (Q4 2025), Vicore Pharma Holding AB's total revenue was kr419.00K, an increase of Infinity% from the same quarter last year. In Q4, Vicore Pharma Holding AB's net income was kr-137.10M. See Vicore Pharma Holding AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 3.82Mkr 109.35Mkr 0.00kr 0.00kr 0.00
Gross Profit
kr 3.82Mkr 109.35Mkr -3.42Mkr -3.61Mkr -3.60M
Operating Expenses
kr 458.26Mkr 303.54Mkr 321.51Mkr 287.49Mkr 293.42M
Depreciation and Amortization
kr 0.00kr 2.24Mkr 3.42Mkr 3.61Mkr 3.60M
EBITDA
kr -454.44Mkr -166.64Mkr -317.47Mkr -286.20Mkr -289.82M
Operating Income
kr -454.44Mkr -194.19Mkr -321.51Mkr -290.73Mkr -294.82M
Other Income/Expenses
kr -23.03Mkr 25.30Mkr 10.18Mkr 1.92Mkr -1.92M
Pretax Income
kr -477.47Mkr -168.89Mkr -311.33Mkr -288.81Mkr -296.74M
Net Income
kr -477.47Mkr -168.63Mkr -310.94Mkr -288.42Mkr -296.48M
Per Share Metrics
Basic EPS
kr -1.99kr -0.75kr -3.22kr -3.99kr -4.25
Diluted EPS
kr -1.99kr -0.75kr -3.22kr -3.99kr -4.25
Weighted Average Shares Outstanding
239.88M 225.32M 96.56M 72.21M 69.68M
Weighted Average Shares Outstanding (Diluted)
239.88M 225.32M 96.56M 72.21M 69.68M
Currency in SEK

Vicore Pharma Holding AB Earnings and Revenue History